Endometrial Receptivity After GnRH Agonist Triggering

Summary

Endometrial Receptivity After GnRH Agonist Triggering is a clinical trial^[1].

Key Facts

• Endometrial Receptivity After GnRH Agonist Triggering is in the country of Spain^[2].
• Endometrial Receptivity After GnRH Agonist Triggering's instance of is recorded as clinical trial^[3].
• Endometrial Receptivity After GnRH Agonist Triggering's start time is recorded as +2011-11-30T00:00:00Z^[4].
• Endometrial Receptivity After GnRH Agonist Triggering's end time is recorded as +2012-05-31T00:00:00Z^[5].
• Endometrial Receptivity After GnRH Agonist Triggering's sponsor is recorded as IVI Madrid Clinic^[6].
• Endometrial Receptivity After GnRH Agonist Triggering's main subject is recorded as ovarian hyperstimulation syndrome^[7].
• Endometrial Receptivity After GnRH Agonist Triggering's number of participants is recorded as {'unit': '1', 'amount': '+35'}^[8].
• Endometrial Receptivity After GnRH Agonist Triggering's title is recorded as Endometrial Receptivity After GnRH Agonist Triggering From Final Oocyte Maturation^[9].
• Endometrial Receptivity After GnRH Agonist Triggering's short name is recorded as ERAMAD^[10].
• Endometrial Receptivity After GnRH Agonist Triggering's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Endometrial Receptivity After GnRH Agonist Triggering's ClinicalTrials.gov ID is recorded as NCT01500863^[12].
• Endometrial Receptivity After GnRH Agonist Triggering's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+35'}^[13].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as 17α-estradiol^[14].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as polyestradiol phosphate^[15].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as progesterone^[16].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as estradiol benzoate^[17].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as estradiol valerate^[18].
• Endometrial Receptivity After GnRH Agonist Triggering's research intervention is recorded as deslorelin^[19].
• Endometrial Receptivity After GnRH Agonist Triggering's clinical trial phase is recorded as phase IV clinical trial^[20].
• Endometrial Receptivity After GnRH Agonist Triggering's research site is recorded as Instituto Valenciano de Infertilidad^[21].
• Endometrial Receptivity After GnRH Agonist Triggering's research subject recruitment status is recorded as completed^[22].
• Endometrial Receptivity After GnRH Agonist Triggering's study type is recorded as interventional study^[23].